High quality, highly expressed mRNA
Advanced sequence and UTR optimization & custom mRNA design, synthesis, purification and analytics for research through Phase I/II clinical trials.
Enabling Next-Generation RNA-Based Therapeutics
Your Partner in mRNA & LNP Design and Manufacturing
Co-founded in 2022 by leading scientists, including Nobel Laureate Dr. Drew Weissman and Dr. Mohamad-Gabriel Alameh.
At RNA Technologies & Therapeutics (RTT), we leverage our unique expertise to consistently manufacture & deliver high-quality, cost-effective mRNA and lipid nanoparticle (LNP) products. Our flexible RUO and GMP solutions span from mRNA design and optimization to LNP formulation, accelerating innovative RNA therapeutics from early research through Phase I/II clinical trials.
We are dedicated to ensuring that breakthrough therapeutics in rare diseases, personalized cancer vaccines, and cell and gene therapies remain affordable and accessible to patients who need them.
Our expertise
LNP formulations
LNP formulation, mRNA encapsulation, process optimization, and manufacturing of targeted and non-targeted LNPs.
Cost-effective research & clinical manufacturing
Flexible RUO and GMP manufacturing supporting research and early clinical programs. End-to-end services, spanning design, manufacturing and QC testing.
The science behind breakthrough therapies
RTT utilizes the same mRNA optimization platform and technical know-how that helped to develop the world’s first personalized gene-editing therapy used to successfully treat Baby KJ.
Acuitas Therapeutics
STRATEGIC PARTNERSHIP
Having worked extensively with RTT over the last number of years, we are impressed with their scientific approach and technical know-how which brings a level of precision and consistency that is critical in RNA drug development. Ultimately, this investment gives our partners a coordinated way to engage experts from both companies as they develop the next-generation RNA-LNP therapies
Off-the-shelf optimized mRNA
(Partial list)
Full list Off-the-shelf products
View full listGene editing and genome engineering
Reporters and imaging
In vivo cell and gene therapies
Multiple species
Antigens
Cancer and infectious diseases, and neoepitopes
Immunomodulators
Others
A new RTT experience is coming soon
We are developing a new website featuring an expanded portfolio of ready-to-use mRNA and LNP products for gene editing, cell engineering and preclinical research, with streamlined online ordering.
We remain fully operational and ready to support your projects.
Let's work together
Contact us to explore our off-the-shelf mRNA and LNP products, discuss custom mRNA and LNP manufacturing projects, or request a quote.